{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:25:07Z","timestamp":1789057507645,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007827","name":"American College of Gastroenterology","doi-asserted-by":"publisher","award":["ACG-FDA Visiting Fellowship Program"],"award-info":[{"award-number":["ACG-FDA Visiting Fellowship Program"]}],"id":[{"id":"10.13039\/100007827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006083","name":"AGA Research Foundation","doi-asserted-by":"publisher","award":["2019 AGA-Shire Research Scholar Award in Functional GI"],"award-info":[{"award-number":["2019 AGA-Shire Research Scholar Award in Functional GI"]}],"id":[{"id":"10.13039\/100006083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006083","name":"AGA Research Foundation","doi-asserted-by":"publisher","award":["Motility Disorders"],"award-info":[{"award-number":["Motility Disorders"]}],"id":[{"id":"10.13039\/100006083","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s10620-020-06252-z","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T10:02:46Z","timestamp":1587031366000},"page":"843-854","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hemophagocytic Lymphohistiocytosis Occurring in Inflammatory Bowel Disease: Systematic Review"],"prefix":"10.1007","volume":"66","author":[{"given":"Elliot S.","family":"Coburn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey A.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3611-8628","authenticated-orcid":false,"given":"Eric D.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"6252_CR1","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Ros\u00e9e","year":"2019","unstructured":"La Ros\u00e9e P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019 Jun;133:2465\u20132477.","journal-title":"Blood."},{"key":"6252_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/JBM.S46255","volume":"5","author":"MR George","year":"2014","unstructured":"George MR. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med. 2014 Jun;5:69\u201386.","journal-title":"J Blood Med."},{"key":"6252_CR3","doi-asserted-by":"crossref","unstructured":"How I treat hemophagocytic lymphohistiocytosis in the adult patient | Blood Journal [Internet]. [cited 2019 Oct 1]. Available from: http:\/\/www.bloodjournal.org\/content\/125\/19\/2908?sso-checked=true","DOI":"10.1182\/blood-2015-01-551622"},{"key":"6252_CR4","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.cgh.2016.04.039","volume":"14","author":"S Bonovas","year":"2016","unstructured":"Bonovas S, Fiorino G, Allocca M, et al. Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis. Clin Gastroenterol Hepatol. 2016 Oct;14:1385\u20131397.e10.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"6252_CR5","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1093\/ecco-jcc\/jjz058","volume":"13","author":"SY Loo","year":"2019","unstructured":"Loo SY, Vutcovici M, Bitton A, et al. Risk of Malignant Cancers in Inflammatory Bowel Disease. J Crohns Colitis. 2019 Sep;13:1302\u20131310.","journal-title":"J Crohns Colitis."},{"key":"6252_CR6","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009 Aug;151:264\u20139, W64."},{"key":"6252_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.semarthrit.2015.07.004","volume":"45","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, Bosch X, P\u00e9rez-de-Lis M, et al. Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies. Semin Arthritis Rheum. 2016 Feb;45:391\u2013399.","journal-title":"Semin Arthritis Rheum."},{"key":"6252_CR8","doi-asserted-by":"crossref","unstructured":"Li Y, Xia X, Zhang J, Song Z, Zhou L, Zhang Y, et al. Haemophagocytic lymphohistiocytosis in inflammatory bowel disease with virus infection. Przegla\u031cd Gastroenterol. 2015;10:78\u201382.","DOI":"10.1016\/S0016-5085(15)30273-0"},{"key":"6252_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/apt.14933","volume":"48","author":"R de Francisco","year":"2018","unstructured":"de Francisco R, Casta\u00f1o-Garc\u00eda A, Mart\u00ednez-Gonz\u00e1lez S, et al. Impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2018 Oct;48:723\u2013730.","journal-title":"Aliment Pharmacol Ther."},{"key":"6252_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/apt.15104","volume":"49","author":"T Ahmed","year":"2019","unstructured":"Ahmed T, Brown F, Ahmed R, et al. Letter: impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2019 Feb;49:476\u2013477.","journal-title":"Aliment Pharmacol Ther."},{"key":"6252_CR11","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1365-2141.2005.05501.x","volume":"129","author":"A Horne","year":"2005","unstructured":"Horne A, Janka G, Egeler RM, et al. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol. 2005;129:622\u2013630.","journal-title":"Br J Haematol."},{"key":"6252_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/apt.12305","volume":"37","author":"W Fries","year":"2013","unstructured":"Fries W, Cottone M, Cascio A. Systematic review: macrophage activation syndrome in inflammatory bowel disease. Aliment Pharmacol Ther. 2013 Jun;37:1033\u20131045.","journal-title":"Aliment Pharmacol Ther."},{"key":"6252_CR13","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","volume":"362","author":"JF Colombel","year":"2010","unstructured":"Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn\u2019s disease. N Engl J Med. 2010 Apr;362:1383\u20131395.","journal-title":"N Engl J Med."},{"key":"6252_CR14","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/j.gastro.2013.10.052","volume":"146","author":"R Panaccione","year":"2014","unstructured":"Panaccione R, Ghosh S, Middleton S, et al. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis. Gastroenterology. 2014 Feb;146:392\u2013400.e3.","journal-title":"Gastroenterology."},{"key":"6252_CR15","unstructured":"Food and Drug Administration. Potential Signals of Serious Risks\/New Safety Information Identified from the FDA Adverse Event Reporting System (FAERS). https:\/\/www.fda.gov\/drugs\/questions-and-answers-fdas-adverse-event-reporting-system-faers\/potential-signals-serious-risksnew-safety-information-identified-fda-adverse-event-reporting-system. Accessed November 19. 2019."},{"key":"6252_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cgh.2010.09.016","volume":"9","author":"DS Kotlyar","year":"2011","unstructured":"Kotlyar DS, Osterman MT, Diamond RH, et al. A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2011 Jan;9:36\u201341.e1.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"6252_CR17","doi-asserted-by":"crossref","unstructured":"Thompson G, Pepperell D, Lawrence I, McGettigan BD. Crohn\u2019s disease complicated by Epstein-Barr virus-driven haemophagocytic lymphohistiocytosis successfully treated with rituximab. BMJ Case Rep. 2017 Feb;bcr2016218578.","DOI":"10.1136\/bcr-2016-218578"},{"key":"6252_CR18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1053\/j.gastro.2015.04.048","volume":"150","author":"C Ma","year":"2016","unstructured":"Ma C, Fedorak RN, Halloran BP. Recurrent Fevers After Infliximab Therapy for Ulcerative Colitis. Gastroenterology. 2016 Jan;150:e1\u2013e2.","journal-title":"Gastroenterology."},{"key":"6252_CR19","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/01.MIB.0000225333.83861.16","volume":"12","author":"DG James","year":"2006","unstructured":"James DG, Stone CD, Wang HL, Stenson WF. Reactive hemophagocytic syndrome complicating the treatment of inflammatory bowel disease: Inflamm Bowel Dis. 2006 Jul;12:573\u2013580.","journal-title":"Reactive hemophagocytic syndrome complicating the treatment of inflammatory bowel disease: Inflamm Bowel Dis."},{"key":"6252_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0755-4982(05)83984-3","volume":"34","author":"\u00c9 Chauveau","year":"2005","unstructured":"Chauveau \u00c9, Terrier F, Casassus-Buihle D, Moncoucy X, Oddes B. Syndrome d\u2019activation macrophagique apr\u00e8s traitement par infliximab pour maladie de Crohn fistulis\u00e9e. Presse M\u00e9dicale. 2005 Apr;34:583\u2013584.","journal-title":"Presse M\u00e9dicale."},{"key":"6252_CR21","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.4045\/tidsskr.15.0958","volume":"136","author":"J Vikse","year":"2016","unstructured":"Vikse J, Cacic DL, Carlsen A, Cooper TJ, Grimstad T. En mann i 30-\u00e5rene med ulcer\u00f8s kolitt og pancytopeni. Tidsskr Den Nor Legeforening. 2016;136:1010\u20131014.","journal-title":"Tidsskr Den Nor Legeforening."},{"key":"6252_CR22","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1086\/500262","volume":"42","author":"MM Kohara","year":"2006","unstructured":"Kohara MM, Blum RN. Cytomegalovirus Ileitis and Hemophagocytic Syndrome Associated with Use of Anti-Tumor Necrosis Factor\u2013 Antibody. Clin Infect Dis. 2006 Mar;42:733\u2013734.","journal-title":"Clin Infect Dis."},{"key":"6252_CR23","first-page":"193","volume":"47","author":"KA Francolla","year":"2008","unstructured":"Francolla KA, Altman A, Sylvester FA. Hemophagocytic Syndrome in an Adolescent With Crohn Disease Receiving Azathioprine and Infliximab: J Pediatr Gastroenterol Nutr. 2008 Aug;47:193\u2013195.","journal-title":"Hemophagocytic Syndrome in an Adolescent With Crohn Disease Receiving Azathioprine and Infliximab: J Pediatr Gastroenterol Nutr."},{"key":"6252_CR24","first-page":"449","volume":"48","author":"T Numakura","year":"2010","unstructured":"Numakura T, Matsuura Y, Takjguchi H, Hara Y, Ameku K, Takashi H. Tuberculosis associated with hemophagocytic syndrome complicated by treatment with infliximab. Nihon Kokyuki Gakkai Zasshi. 2010 Jun;48:449\u2013453.","journal-title":"Nihon Kokyuki Gakkai Zasshi."},{"key":"6252_CR25","doi-asserted-by":"crossref","unstructured":"Presti MAL, Costantino G, della Torre A, Belvedere A, Cascio A, Fries W. Severe CMV-related pneumonia complicated by the hemophagocytic lymphohistiocytic (HLH) syndrome in quiescent Crohn\u02bcs colitis: Harmful cure?: Inflamm Bowel Dis. 2011 Nov;17:E145\u20136.","DOI":"10.1002\/ibd.21828"},{"key":"6252_CR26","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/ajg.2008.24","volume":"104","author":"T Miquel","year":"2009","unstructured":"Miquel T, Bonnet DPA, Leport J, Longuet P, Bletry O, Leport C. Hemophagocytic Syndrome in the Course of Crohn\u2019s Disease: Possible Association With Cytomegalovirus Infection. Am J Gastroenterol. 2009 Jan;104:252\u2013252.","journal-title":"Am J Gastroenterol."},{"key":"6252_CR27","first-page":"E143","volume":"17","author":"CT Salado","year":"2011","unstructured":"Salado CT, Gallego AG, Carnerero EL, et al. Hemophagocytic lymphohistiocytosis in Crohn\u02bcs disease associated with primary infection by Epstein-Barr virus: Inflamm Bowel Dis. 2011 Nov;17:E143\u2013E144.","journal-title":"Hemophagocytic lymphohistiocytosis in Crohn\u02bcs disease associated with primary infection by Epstein-Barr virus: Inflamm Bowel Dis."},{"key":"6252_CR28","doi-asserted-by":"crossref","unstructured":"N\u02bcGuyen Y, Baumard S, Salmon JH, Lemoine L, L\u00e9v\u00eaque N, Servettaz A, et al. Cytomegalovirus associated hemophagocytic lymphohistiocytosis in patients suffering from crohn\u02bcs disease treated by azathioprine: A series of four cases: Inflamm Bowel Dis. 2011 Sep;17:E116\u20138.","DOI":"10.1002\/ibd.21770"},{"key":"6252_CR29","first-page":"S609","volume":"32","author":"A Beck","year":"2017","unstructured":"Beck A, Mullally J, Agonafer E, Trifan A. TB or not TB? The drama unfolds with macrophage activaiton syndrome (MAS). J Gen Intern Med. 2017;32:S609.","journal-title":"J Gen Intern Med."},{"key":"6252_CR30","doi-asserted-by":"publisher","first-page":"S304","DOI":"10.14309\/00000434-201510001-00687","volume":"110","author":"N Avila","year":"2015","unstructured":"Avila N, Guider J, Avila M, Thosani N, Reddy S. Disseminated histoplasmosis: A case that warns of consequences of immunosuppression in IBD. Am J Gastroenterol. 2015 Oct;110:S304.","journal-title":"Am J Gastroenterol."},{"key":"6252_CR31","first-page":"S143","volume":"9","author":"T Ogashiwa","year":"2015","unstructured":"Ogashiwa T, Kunisaki R, Yasuhara H, et al. Clinical, morphological and histological features of X-linked lymphoproliferative syndrome type 2 enteritis diagnosed in three cases with childhood onset inflammatory bowel disease. J Crohns Colitis. 2015;9:S143.","journal-title":"J Crohns Colitis."},{"key":"6252_CR32","doi-asserted-by":"publisher","first-page":"S434","DOI":"10.1016\/j.crohns.2014.01.005","volume":"8","author":"J Martin-de-Carpi","year":"2014","unstructured":"Martin-de-Carpi J, Ruiz C, Sanchez D, et al. Bone marrow toxicity secondary to primary infection by Epstein Barr virus in a patient with Crohn\u2019s disease treated with thiopurines. J Crohns Colitis. 2014;8:S434.","journal-title":"J Crohns Colitis."},{"key":"6252_CR33","doi-asserted-by":"crossref","unstructured":"Yellu M, Medlin S. Secondary hemophagocytic lymphohistiocytosis as a presentation for peripheral T-cell lymphoma. Blood. 2013;122.","DOI":"10.1182\/blood.V122.21.5068.5068"},{"key":"6252_CR34","doi-asserted-by":"publisher","first-page":"e977","DOI":"10.1542\/peds.2010-0486","volume":"126","author":"M Deneau","year":"2010","unstructured":"Deneau M, Wallentine J, Guthery S, et al. Natural killer cell lymphoma in a pediatric patient with inflammatory bowel disease. Pediatrics. 2010 Oct;126:e977\u2013e981.","journal-title":"Pediatrics."},{"key":"6252_CR35","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1155\/2011\/148927","volume":"25","author":"J C\u00f4t\u00e9-Daigneault","year":"2011","unstructured":"C\u00f4t\u00e9-Daigneault J, Bernard E-J. Hepatosplenic lymphoma presenting initially as hemophagocytic syndrome in a 21-year-old man with Crohn\u2019s disease: a case report and literature review. Can J Gastroenterol J Can Gastroenterol. 2011 Aug;25:417\u2013418.","journal-title":"Can J Gastroenterol J Can Gastroenterol."},{"key":"6252_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/MPG.0b013e3181e80410","volume":"52","author":"D Gidrewicz","year":"2011","unstructured":"Gidrewicz D, Lehman D, Rabizadeh S, Majlessipour F, Dubinsky M. Primary EBV infection resulting in lymphoproliferative disease in a teenager with Crohn disease. J Pediatr Gastroenterol Nutr. 2011 Jan;52:103\u2013105.","journal-title":"J Pediatr Gastroenterol Nutr."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06252-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-020-06252-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06252-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:47:55Z","timestamp":1618534075000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-020-06252-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["6252"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06252-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]},"assertion":[{"value":"15 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"CAS serves as a consultant\/advisory board for Abbvie, Amgen, Celgene, Lilly, Janssen, Sandoz, Pfizer, Prometheus, Sebela, and Takeda; as a speaker for CME activities for Abbvie, Janssen, Pfizer, and Takeda; and has received grant support from the Crohn\u2019s and Colitis Foundation, AHRQ (1R01HS021747-01), Abbvie, Janssen, Pfizer, and Takeda. The other authors have no personal or financial disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}